Valeriy Domenyuk

This inventor holds 10 USPTO granted patents and 9 published patent applications, plus 4 CIPO patents and 6 EPO patents. Top assignees: Caris Science, Inc., Arizona State University, Caris Life Sciences Switzerland Holdings Gmbh. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Valeriy Domenyuk. Retrieved from https://idiyas.com/inventor/valeriy-domenyuk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 9)

% Patents Active = 90.0

CIPO Patents = 4 (Patent Applications = 4)

EPO Patents = 6 (Patent Applications = 10)

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 48(Granted Patents)

Location History:

Tempe, AZ (US) (2016 - 2021)
Phoenix, AZ (US) (2020 - 2022)

Company Filing History:

Arizona State University

patents

2 out of 6

Caris Life Sciences Switzerland Holdings Gmbh

patents

Years Active: 2016-2026

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12606814 - Oligonucleotide probes and uses thereof (2026-04-21),

2. 11332748 - Oligonucleotide probes and uses thereof (2022-05-17),

3. 11293017 - Oligonucleotide probes and uses thereof (2022-04-05),

4. 10942184 - Aptamers and uses thereof (2021-03-09),

5. 10731166 - Oligonucleotide probes and uses thereof (2020-08-04),

6. 10011649 - High affinity synbodies for influenza (2018-07-03),

7. 9958448 - Aptamers and uses thereof (2018-05-01),

8. 9939443 - Compositions and methods for aptamer screening (2018-04-10),

9. 9482666 - High throughput selection of specific cell binding and lytic polypeptides (2016-11-01),

10. 9309298 - Anti-bacterial polypeptides and pathogen specific synthetic antibodies (2016-04-12),

Title: Valeriy Domenyuk: Innovator in Oligonucleotide Technologies

Introduction

Valeriy Domenyuk is a prominent inventor based in Tempe, AZ, known for his groundbreaking work in the field of molecular biology. With a portfolio of 9 patents, Domenyuk has significantly contributed to the development of oligonucleotide probes that have vital applications in diagnostics and therapeutics, particularly in identifying and targeting various biomarkers associated with diseases.

Latest Patents

One of Valeriy's latest patents focuses on oligonucleotide probes and their uses, detailing methods and compositions that identify oligonucleotides binding to targets of interest. These targets encompass tissues, cells, and circulating biomarkers such as microvesicles, which are instrumental in diagnosing and treating diseases. This innovation showcases his commitment to enhancing diagnostic accuracy and therapeutic effectiveness through advanced molecular techniques.

Career Highlights

Throughout his career, Domenyuk has held significant positions that allowed him to influence the integration of innovative science into practical health solutions. Notably, he has worked with Caris Life Sciences, Inc. and Arizona State University, where he utilized his expertise to advance research initiatives and contribute to the scientific community.

Collaborations

Valeriy has collaborated with esteemed professionals in the field, including David Spetzler and Tassilo Hornung. These partnerships have enriched his work and facilitated the advancement of knowledge in oligonucleotide technology, reflecting the collaborative spirit that drives innovation in research and development.

Conclusion

Valeriy Domenyuk stands out as an influential figure in the realm of oligonucleotide research. His contributions through patents and collaborations emphasize the importance of innovation in medical diagnostics and therapeutic applications. As he continues to develop his ideas, the impact of his work is likely to resonate through the scientific community and beyond, paving the way for future breakthroughs.

Profile summary based on public USPTO records.